Parathyroid Hormone Therapy in Treating Postmenopausal and Glucocorticoid-Induced Osteoporosis
Osteoporosis affects millions of lives worldwide by causing weakened bones that enhance the risk of fractures. The prevalence of osteoporosis is seen in individuals on long-term glucocorticoid therapy and postmenopausal women. Physicians have effectively mitigated the complications of osteoporosis by using next-generation medications. This article will comprehensively explain the symptoms, causes and treatment options of osteoporosis so that patients can get an overall knowledge of this clinical condition. What is Osteoporosis ? Osteoporosis primarily results from an imbalance in bone remodelling, where bone resorption outpaces bone formation. This imbalance leads to decreased bone mineral density (BMD) and a porous bone structure. Postmenopausal women are particularly susceptible due to the decline in estrogen levels, which accelerates bone loss. Similarly, prolonged glucocorticoid use, often prescribed for chronic inflammatory conditions, inhibits bone formation and increases ...